MX9700298A - Adenovirus que comprende un gen que codifica para una no sintasa. - Google Patents

Adenovirus que comprende un gen que codifica para una no sintasa.

Info

Publication number
MX9700298A
MX9700298A MX9700298A MX9700298A MX9700298A MX 9700298 A MX9700298 A MX 9700298A MX 9700298 A MX9700298 A MX 9700298A MX 9700298 A MX9700298 A MX 9700298A MX 9700298 A MX9700298 A MX 9700298A
Authority
MX
Mexico
Prior art keywords
synthase
gene coding
adenovirus
restenosis
treatment
Prior art date
Application number
MX9700298A
Other languages
English (en)
Spanish (es)
Inventor
Andrees Bohme
Didier Branellec
Patrice Denefle
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of MX9700298A publication Critical patent/MX9700298A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0073—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen 1.14.13
    • C12N9/0075—Nitric-oxide synthase (1.14.13.39)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/13—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen (1.14.13)
    • C12Y114/13039—Nitric-oxide synthase (NADPH dependent) (1.14.13.39)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
MX9700298A 1994-07-12 1995-07-07 Adenovirus que comprende un gen que codifica para una no sintasa. MX9700298A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9408657A FR2722507B1 (fr) 1994-07-12 1994-07-12 Adenovirus comportant un gene codant pour une no synthase
PCT/FR1995/000913 WO1996001902A1 (fr) 1994-07-12 1995-07-07 Adenovirus comportant un gene codant pour une no synthase

Publications (1)

Publication Number Publication Date
MX9700298A true MX9700298A (es) 1997-05-31

Family

ID=9465319

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9700298A MX9700298A (es) 1994-07-12 1995-07-07 Adenovirus que comprende un gen que codifica para una no sintasa.

Country Status (11)

Country Link
EP (1) EP0770133A1 (fr)
JP (1) JPH10502533A (fr)
AU (1) AU691008B2 (fr)
CA (1) CA2193263A1 (fr)
FI (1) FI970114A (fr)
FR (1) FR2722507B1 (fr)
IL (1) IL114565A0 (fr)
MX (1) MX9700298A (fr)
NO (1) NO970048L (fr)
WO (1) WO1996001902A1 (fr)
ZA (1) ZA955797B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5833651A (en) * 1996-11-08 1998-11-10 Medtronic, Inc. Therapeutic intraluminal stents
WO1999041398A1 (fr) * 1998-02-11 1999-08-19 Genvec, Inc. Vecteurs, cellules et procedes de production de vecteurs de transfert de genes eucaryotes, viraux et deleteres
US6206914B1 (en) 1998-04-30 2001-03-27 Medtronic, Inc. Implantable system with drug-eluting cells for on-demand local drug delivery
EP1020520A1 (fr) * 1999-01-15 2000-07-19 Introgene B.V. Prévention d'élimination immunologiques des cellules du corps mammifère, molécules PML mutantes utiles à cet effet
SK14692001A3 (sk) * 1999-04-16 2002-09-10 Yale University Izolovaná molekula nukleovej kyseliny, izolovaný NOS polypeptid, spôsob stimulácie, spôsob liečby, spôsob identifikácie a nehumánne transgénne zviera
FR2793142A1 (fr) * 1999-05-04 2000-11-10 Aventis Pharma Sa Utilisation d'oligonucleotides antisens de no-synthase inductible dans la prevention et le traitement de l'ischemie cerebrale
AU5081200A (en) * 1999-05-04 2000-11-17 Aventis Pharma S.A. Use of inducible no-synthase antisense oligonucleotides for preventing and treating cerebral ischemia
EP1067190A1 (fr) * 1999-07-09 2001-01-10 Introgene B.V. Thérapie génique pour l'amélioration et/ou induction de l'angiogénèse
EP1076091A1 (fr) * 1999-08-09 2001-02-14 Universite Catholique De Louvain Composé ou composition pharmaceutique pour la prévention et/ou le traitement d'ischémie cardiaque, de maladies vasculaires périphériques, de tumeurs et de plaies

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5281627A (en) * 1992-05-28 1994-01-25 Cornell Research Foundation, Inc. Substituted arginines and substituted homoarginines and use thereof
EP0957172B1 (fr) * 1992-11-18 2005-10-19 Arch Development Corporation Transfert de genes au muscle lisse cardiaque et musculaire au moyen d'un adenovirus
FR2704556B1 (fr) * 1993-04-30 1995-07-13 Rhone Poulenc Rorer Sa Virus recombinants et leur utilisation en thérapie génique.
FR2705361B1 (fr) * 1993-05-18 1995-08-04 Centre Nat Rech Scient Vecteurs viraux et utilisation en thérapie génique.
EP0702518B1 (fr) * 1993-06-11 2003-04-02 The Board Of Trustees Of The Leland Stanford Junior University Traitement des maladies vasculaires degeneratives par modulation de l'activite ou de la production d'oxyde nitrique endogene
FR2707494B1 (fr) * 1993-07-02 1995-08-25 Roussel Uclaf Nouvelle utilisation de dérivés de la béta-naphtoquinone ainsi que de leurs sels.
US6682728B1 (en) * 1993-10-13 2004-01-27 The United States Of America As Represented By The Department Of Health And Human Services Efficient and selective adenoviral-mediated gene transfer into vascular neointima

Also Published As

Publication number Publication date
NO970048D0 (no) 1997-01-07
AU2930695A (en) 1996-02-09
FI970114A0 (fi) 1997-01-10
NO970048L (no) 1997-01-07
FR2722507A1 (fr) 1996-01-19
FR2722507B1 (fr) 1996-08-14
CA2193263A1 (fr) 1996-01-25
IL114565A0 (en) 1995-11-27
WO1996001902A1 (fr) 1996-01-25
AU691008B2 (en) 1998-05-07
JPH10502533A (ja) 1998-03-10
FI970114A (fi) 1997-01-10
EP0770133A1 (fr) 1997-05-02
ZA955797B (en) 1996-02-26

Similar Documents

Publication Publication Date Title
YU15299A (sh) Farmaceutski sastavi
HUT72558A (en) Defective adenovirus vectors and use thereof in gene therapy
UA66417C2 (en) Recombinant adenovirus affecting canines, pharmaceutical composition
IL134042A0 (en) Modified dorsal tissue affecting factor and compositions
DE69905170D1 (en) Thiazolopyrimidinderivate
IL111734A0 (en) Compositions for the preparation of in vivo therapeutic products
EP0571442A4 (fr) Proteine tsg-14 induite par la cytokine, adn codant cette proteine et ses utilisations.
EP0659769A3 (fr) Agent pour promouvoir la prolifération de bifidobactérium.
HU0500549D0 (en) Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof
MX9707570A (es) Utilizacion de agonistas de alta1l para el tratamiento de la incontinencia urinaria.
ZA973022B (en) New pharmaceutical composition with anaesthetic effect.
WO1996035784A3 (fr) Genes de regulation de la chromatine
IL114904A0 (en) Adenovirus comprising a gene encoding glutathione peroxidase
ZA9811445B (en) Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions.
MY114140A (en) Novel enzymes and prodrugs for use in antibody-directed enzyme prodrug therapy.
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
ZA978842B (en) Use of an H<+>, K<+>-ATPase inhibitor in the treatment of nasal polyps.
MX9700298A (es) Adenovirus que comprende un gen que codifica para una no sintasa.
ZA973622B (en) Use of forms of hyaluronic acid (HA) for the treatment of cancer.
NZ320259A (en) Deodorizing preparations containing cationic biopolymers, aluminium hydrochlorate and esterase inhibitors
AU6063900A (en) Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
ZA98420B (en) Use of pramipexole in the treatment of restless legs syndrome.
RS47804A (en) 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof
EP1045914B8 (fr) Svph1-8 proteinase humaine specifique aux testicules
WO1998050397A3 (fr) Oligonucleotides chimeriques et leur utilisation